An important aspect of this burden is the co-occurrence of disorders of glucose and insulin homeostasis (DGIH) [type-2 diabetes mellitus (T2DM) and prediabetes] and obesity (Roy and Lloyd, 2012; Vancampfort et al., 2016). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.